April 21, 2026
The blood pressure measuring devices market is expected to see growth from USD 2.08 billion in 2026 to USD 4.5...
Read MoreMay 18, 2026
The smart healthcare market is expected to rise from USD 397.98 billion in 2026 to USD 1833.7 billion by 2035,...
Read MoreJune 04, 2026
The simulators market size is forecast to increase from USD 14.71 billion in 2026 to USD 27.59 billion by 2035...
Read MoreJanuary 19, 2026
The U.S. digital health market size is forecast to increase from USD 98.69 billion in 2026 to USD 266.5 billio...
Read MoreFebruary 24, 2026
Based on our market forecasts, the pancreatic cancer precision medicine sector will expand from USD 815.63 million in 2025 to USD 4739.26 million by 2035, experiencing a CAGR of 19.24%....
February 23, 2026
According to projections, the global topical drug delivery market, valued at USD 268.96 billion in 2025, is anticipated to reach USD 622.85 billion by 2035, growing at a CAGR of 8.76% over the next decade. A widespread increase in cases of diverse skin diseases is fueling enhanced adoption of topical treatments and overall global market expa...
February 23, 2026
Based on market forecasts, the global ophthalmology drugs market, projected at USD 45.52 billion in 2025, is expected to reach USD 76.51 billion by 2035, growing at a CAGR of 5.33% over the forecast period. The ophthalmology drugs market is growing due to the rising geriatric population, and North America is dominating because of the rising resea...
February 20, 2026
Projections indicate that, the global monoclonal antibodie market will increase from USD 254.89 billion in 2024 to USD 823.31 billion by 2034, experiencing a CAGR of 12.44% over the next 10 years. The monoclonal antibodies market is expanding due to growing demand for targeted therapies as well as rising bispecific antibody treatment approaches. ...
February 20, 2026
Based on our estimations, the intravenous iron drugs market was valued at USD 3.65 billion in 2025 and reached USD 3.98 billion in 2026, and is projected to grow to USD 8.74 billion by 2035, expanding at a CAGR of 9.14% (2026–2035)....
February 19, 2026
According to market projections, the vaccine adjuvant sector is expected to grow from USD 747.6 million in 2025 to USD 1394.15 million by 2035, reflecting a CAGR of 6.43%.The market is growing due to rising demand for stronger and longer-lasting immune responses....
February 19, 2026
According to our forecasts, the invasive fungal disease (IFD) drugs market was valued at USD 3.11 billion in 2025 and is projected to grow from USD 3.29 billion in 2026 to USD 5.34 billion by 2035, expanding at a CAGR of 5.55% during 2026–2035....
February 17, 2026
The global cystic fibrosis therapeutics market expected to reach USD 44.72 billion by 2035, growing at a CAGR of 14.24% over the forecast period. In 2024, North America dominated the market, while Asia-Pacific is set for the fastest growth. CFTR modulators led by drug class, with pancreatic enzyme supplements projected for the highest CAGR. Oral ad...
February 17, 2026
According to market projections, the global bispecific antibody market, valued at USD 17.24 billion in 2025, is anticipated to reach USD 662.84 billion by 2035, growing at a CAGR of 44.04% over the next decade. The bispecific antibody market is expanding due to increasing occurrences of cancer as well as rising developments. North America led the m...
February 17, 2026
According to market projections, the subcutaneous biologics sector is expected to grow from USD 2.1 billion in 2025 to USD 6.01 billion by 2035, reflecting a CAGR of 11.09%. The growing demand for self-administration and the need for targeted therapy bolster the market. North America dominated the global market owing to its advanced healthcare infr...
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
